Giovanni B Frisoni CURRICULUM VITAE - centro alzheimer

Fatebenefratelli per la Ricerca, the scientific arm of the Fatebenefratelli (St John of God) hospital
network. St John of God Brotherhood Order is the largest private multinational health corporation,
featuring 389 health care facilities in 49 countries of 5 continents.
2000‐to date: founding editorial board member of The Lancet Neurology.
1995‐to date: editorial board member of Journal of Neurology, Alzheimer Disease & Associated
Disorders, Aging Clinical and Experimental Research, and a number of other minor international
scientific journals.
12. GRANTS
Grants as a Principal Investigator
Only in the past 2 years (since 2008), I have brought about € 5M to the IRCCS‐FBF, as can be
appreciated by the list below. This should be placed in the context of the relatively small research
facility where I am working. The IRCCS‐FBF lives almost exclusively (except for the grants reported
below) on about € 2M per year from the Italian Ministry of Healh (socalled Ricerca Corrente). Of these
funds, about 10% goes to my Unit (LENITEM). Thus, my research lives for the vast part on external
grants.
� 2011: Principal Investigator of CoEN GENFI: “The GENetic Frontotemporal Dementia Initiative
(GENFI): a new multi‐centre platform for the study of frontotemporal lobar degeneration” , a £ 455K
project.
� 2011: Principal Investigator of NeuGRID for you – An expansion of NeuGRID services and outreach
to new user communities a € 3,6 M project funded under EC FP7
� 2010: Principal Investigator of “Harmonization of Protocols for the Manual Tracing of the
Hippocampus – Development and Validation of a Unified Standard Protocol: an EADC‐ADNI Joint
Effort”, a US$ 200K project funded by the Alzheimer’s Association (http://www.hippocampal‐
protocol.net.
� 2009: Principal Investigator of outGRID ‐ A Worldwide e‐Infrastructure for Computational
Neuroscientists, a € 440K project funded under EC FP7 (www.outGRID.eu).
� 2009: Leader of Workpackage 5 Human Studies on Disease Modifying Drugs, a € 4.5M workpackage
in the context of € 22M IMI‐funded PHARMACOG – Prediction of Cognitive Properties of New Drug
Candidates for NeuroDegenerative Diseases in Early Clinical Development
(http://www.centroalzheimer.org/sito/ip_pharma_cog.php). The funding to IRCCS‐FBF is € 1M.
� 2009: Principal Investigator of Molecular Imaging for the Early Diagnosis and Monitoring of
Alzheimer’s Disease in Old Individuals with Cognitive Disturbances: an ADNI‐Compatible Prospective
Study, a € 300K project funded by the Italian Ministry of Health.
� 2008: Principal Investigator of neuGRID ‐ A Grid‐Based e‐Infrastructure for Data Archiving/
Communication and Computationally Intensive Applications in the Medical Sciences, a € 2.8 M
project funded under EC FP7 (www.neuGRID.eu).
� 2008: Principal Investigator of Diagnosis of incipient Alzheimer disease: development of ADNI‐based
imaging markers for use by the National Health System, a € 400K project funded by the Italian
8